Hemispherx Biopharma Announces Financial Results for the Three Months Ended March 31, 2017
May 15, 2017 21:24 pm UTC| Business
PHILADELPHIA, May 15, 2017 -- Hemispherx Biopharma (NYSE MKT:HEB) announced its financial results for the three months ended March 31, 2017. The net loss was approximately $2,821,000 or ($0.11) per share as compared to...
Former Midland National CEO William Rigsbee Passes Away
May 15, 2017 21:18 pm UTC| Business
SIOUX FALLS, S.D., May 15, 2017 -- Former Midland National® Life Insurance Company President and Chief Executive Officer William A. Rigsbee passed away on May 1, 2017. Rigsbee joined Midland National in 1961, retiring...
May 15, 2017 21:16 pm UTC| Business
VISTA, Calif., May 15, 2017 -- Flux Power Holdings, Inc. (OTCQB:FLUX), a developer of advanced lithium batteries for industrial applications including electric forklifts and airport ground support equipment, today...
Accelerate Diagnostics Announces Closing of $79.3 Million Upsized Offering
May 15, 2017 21:14 pm UTC| Business
TUCSON, Ariz., May 15, 2017 -- Accelerate Diagnostics, Inc. (Nasdaq:AXDX) announced the closing of its previously announced underwritten public offering of 2,750,000 shares of its common stock today, upsized from the...
Financial Institutions, Inc. Announces Commencement of Common Stock Offering
May 15, 2017 21:14 pm UTC| Business
WARSAW, N.Y., May 15, 2017 -- Financial Institutions, Inc. (NASDAQ:FISI) (the “Company”), the parent company of Five Star Bank, Scott Danahy Naylon, LLC and Courier Capital, LLC, today announced that it has commenced an...
Miramar Labs, Inc.® Reports Q1 2017 Financial Results
May 15, 2017 21:08 pm UTC| Business
Highlights: - First quarter revenue of $3.8 million- Strong sales in Europe/Middle East with 26% year-over-year growth- Continued momentum in North America sales with 18% year-over-year growth- Decline in Asia sales of...
Caladrius Biosciences Announces 2017 First Quarter Financial Results
May 15, 2017 21:07 pm UTC| Business
BASKING RIDGE, N.J., May 15, 2017 -- Caladrius Biosciences, Inc. (NASDAQ:CLBS) (“Caladrius” or the “Company”), a cell therapy company with a therapeutic development pipeline focused on immune modulation and select...